Earli website screenshot

Earli

Earli is a biotech company using AI-designed genetic switches for early cancer detection and treatment. Its synthetic-biomarker technology forces cancer cells to reveal themselves for earlier, more accurate detection, and can program cancer cells to self-destruct while sparing healthy tissue. Founded by Cyriac Roeding and backed by a16z and Menlo Ventures, Earli is a research-stage company with no public developer platform, API, or SDK surface. This profile was added to the API Evangelist network as a venture-portfolio lead awaiting further enrichment.

Earli is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Healthcare, Cancer Detection, and Diagnostics.

Earli’s developer surface includes engineering blog and 3 more developer resources.

6.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyHealthcareCancer DetectionDiagnosticsLife SciencesArtificial Intelligence

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 6.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/earli: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Earli Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 1

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: earli
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/earli.png
name: Earli
description: Earli is a biotech company using AI-designed genetic switches for early cancer detection and treatment. Its synthetic-biomarker
  technology forces cancer cells to reveal themselves for earlier, more accurate detection, and can program cancer cells to
  self-destruct while sparing healthy tissue. Founded by Cyriac Roeding and backed by a16z and Menlo Ventures, Earli is a
  research-stage company with no public developer platform, API, or SDK surface. This profile was added to the API Evangelist
  network as a venture-portfolio lead awaiting further enrichment.
url: https://raw.githubusercontent.com/api-evangelist/earli/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
- menlo-ventures
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Healthcare
- Cancer Detection
- Diagnostics
- Life Sciences
- Artificial Intelligence
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://earli.com
- type: PrivacyPolicy
  url: https://earli.com/privacy-policy
- type: Blog
  url: https://earli.com/news
- type: DomainSecurity
  url: security/earli-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence